Fakih IVF Fertility Center Expands Its Footprint in the UAE with the Launch of a New Centre in Al Ain

Global infertility treatment market is projected to reach USD 2.2 billion by 2023 from USD 1.5 billion in 2018

Expanding its services and operations in the UAE, Fakih IVF Fertility Center – the Middle East’s leading fertility services provider launched a new facility in Al Ain on December 5, 2018. 

The new clinic, Fakih IVF’s fourth in the GCC region, is part of a vision to be the worldwide leader in fertility treatment. The new centre was inaugurated by Prasanth Manghat, CEO and Executive Director of NMC Healthcare; Dr. Michael Fakih, Medical Director of Fakih IVF in the presence of senior staff and management from NMC Healthcare and Fakih IVF Fertility Center.

“We are thrilled to launch our new facility in Al Ain. We have created an advanced centre by recruiting the finest talent and adopting the best practices and procedures from across the globe. The launch of this new facility reinforces our commitment to expansion and we are confident that the new facility will present the community and patients with significant fertility solutions,” said Mr. Manghat.

Renowned for its quality patient care, infrastructure, technology and highly experienced team of fertility experts, Fakih IVF also has clinics in Abu Dhabi, Dubai and Muscat. The new centre features state-of-the-art facilities and advanced technologies to significantly improve the chances of a pregnancy following in-vitro fertilization treatments, even for patients with multiple previous failures. With embryologists, andrologists, doctors, counsellors and nursing staff, the new fertility centre will offer specialised treatments including genetic testing, fertility preservation and gender selection. 

Mr. Manghat added, “Fakih IVF Fertility Center has always been committed to patients’ well-being. The new centre will provide services of the highest international standards and offer easier access to patients residing in the emirate.” 
The global market for infertility treatments is projected to reach USD 2.2 billion by 2023, as compared to USD 1.5 billion in 2018.